Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts.

Coppola, Antonio; Marrone, Emiliana; Conca, Paolo; Cimino, Ernesto; Mormile, Rosaria; Baldacci, Erminia; Santoro, Cristina

Coppola, Antonio; Marrone, Emiliana; Conca, Paolo; Cimino, Ernesto; Mormile, Rosaria; Baldacci, Erminia; Santoro, Cristina.

Afiliação

Coppola A; Regional Reference Center for Coagulation Disorders, Federico II University Hospital Naples, Naples, Italy.
Marrone E; Regional Reference Center for Coagulation Disorders, Federico II University Hospital Naples, Naples, Italy.
Conca P; Regional Reference Center for Coagulation Disorders, Federico II University Hospital Naples, Naples, Italy.
Cimino E; Regional Reference Center for Coagulation Disorders, Federico II University Hospital Naples, Naples, Italy.
Mormile R; Regional Reference Center for Coagulation Disorders, Federico II University Hospital Naples, Naples, Italy.
Baldacci E; Hematology, Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
Santoro C; Hematology, Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.

Semin Thromb Hemost ; 42(5): 563-76, 2016 Jul.

Article em En | MEDLINE | ID: mdl-27257871

Assuntos

Substituição de Medicamentos; Fator VIII/uso terapêutico; Hemofilia A/tratamento farmacológico; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Substituição de Medicamentos / Hemofilia A Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Semin Thromb Hemost Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google